المؤلفون: Castoldi F, Rossi R, Lollino N, Renzulli F, Berrino E, Rossi P, Castoldi, Filippo, Rossi, Roberto, Lollino, Nicola, Renzulli, Federico, Berrino, Elena, Rossi, Paolo

المصدر: Knee Surgery, Sports Traumatology, Arthroscopy; Jan2008, Vol. 16 Issue 1, p81-85, 5p

المؤلفون: MARTINETTO P., GARIGLIO M., BERRINO E., CAVALLO GP, MALCANGI A., POZZAN P., FARRI, Alessandro

المساهمون: MARTINETTO P, GARIGLIO M, BERRINO E, FARRI A, CAVALLO GP, MALCANGI A, POZZAN P

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/3833566; volume:32; firstpage:295; lastpage:298; journal:GIORNALE ITALIANO DI CHEMIOTERAPIA; http://hdl.handle.net/2318/29794Test

الإتاحة: http://hdl.handle.net/2318/29794Test

المؤلفون: Martinetto, P., Gariglio, M., Berrino, E., Farri, Alessandro, Cavallo, Gp, Malcangi, A., Pozzan, P.

المصدر: Giornale italiano di chemioterapia. 32(2)

مصطلحات موضوعية: Otitis Media, Mezlocillin, Staphylococcus, Drug Evaluation, Humans, Microbial Sensitivity Tests, Staphylococcal Infections

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::faf1863960908692513936eca243ed17Test
https://pubmed.ncbi.nlm.nih.gov/3833566Test

المؤلفون: Berrino E., Angeli A., Zhdanov D.D., Kiryukhina A.P., Milaneschi A., Bozdag M., Carradori S., Selleri S., Bartolucci G., Peat T.S., Ferraroni M., Supuran C.T., Carta F., De Luca A.

المصدر: Journal of Medicinal Chemistry

مصطلحات موضوعية: 1 [4 [4 [[(2,2 dioxidobenzo[e][1,2]oxathiin 6 yl)oxy]methyl] 1h 1,2,3 triazol 1 yl] 5 (hydroxymethyl)tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1 [5 (hydroxymethyl) 4 [4 [3 [(2 oxo 2h chromen 6 yl)oxy]propyl] 1h 1,2,3 triazol 1 yl]tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1 [5 (hydroxymethyl) 4 [4 [3 [(2 oxo 2h chromen 7 yl)oxy]propyl] 1h 1,2,3 triazol 1 yl]tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1 [5 (hydroxymethyl) 4 [4 [4 [(2 oxo 2h chromen 4 yl)oxy]butyl] 1h 1,2,3 triazol 1 yl]tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1 [5 (hydroxymethyl) 4 [4 [4 [(2 oxo 2h chromen 7 yl)oxy]butyl] 1h 1,2,3 triazol 1 yl]tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1 [5 (hydroxymethyl) 4 [4 [[(2 oxo 2h chromen 6 yl)oxy]methyl] 1h 1,2,3 triazol 1 yl]tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1 [5 (hydroxymethyl) 4 [4 [[(2 oxo 2h chromen 7 yl)oxy]methyl] 1h 1,2,3 triazol 1 yl]tetrahydrofuran 2 yl] 5 methylpyrimidine 2,4(1h,3h)dione, 1,2,3 triazole derivative, 3 [3 [4 [[[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]selanyl]phenyl]thioureido]benzenesulfonamide, 3 [3 [[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]ureido]benzenesulfonamide, 3 [[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl] 2 oxo 2,3 dihydrobenzo[d]oxazole 5 sulfonamide, 4 [2 [bis[[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]amino]ethyl]benzenesulfonamide, 4 [3 [4 [[[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]selanyl]phenyl]thioureido]benzenesulfonamide, 4 [3 [[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]ureido]benzenesulfonamide, 4 [bis[[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]amino]benzenesulfonamide, 4 [[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methoxy]benzenesulfonamide, 4 [[[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]amino]benzenesulfonamide, 4 [[[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl]thio]benzenesulfonamide, acetazolamide, carbonate dehydratase inhibitor, carbonate dehydratase IX, carbonate dehydratase XII, n [[1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl] 4 sulfamoylbenzamide, telomerase inhibitor, unclassified drug, zidovudine, [1 [2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl] 1h 1,2,3 triazol 4 yl]methyl 4 sulfamoylbenzoate, [1 [[2 (hydroxymethyl) 5 (5 methyl 2,4 dioxo 3,4 dihydropyrimidin 1(2h)yl)tetrahydrofuran 3 yl]methyl] 1h 1,2,3 triazol 4 yl]methyl 4 chloro 3 sulfamoylbenzoate, antineoplastic activity, Article

العلاقة: https://doi.org/10.1021/acs.jmedchem.0c00636Test; https://repository.rudn.ru/records/article/record/64540Test/

الإتاحة: https://doi.org/10.1021/acs.jmedchem.0c00636Test
https://repository.rudn.ru/records/article/record/64540Test/

المؤلفون: Plyasova A.A., Berrino E., Khan I.I., Veselovsky A.V., Pokrovsky V.S., Angeli A., Ferraroni M., Supuran C.T., Pokrovskaya M.V., Alexandrova S.S., Gladilina Y.A., Sokolov N.N., Hilal A., Carta F., Zhdanov D.D.

المصدر: Journal of Medicinal Chemistry

مصطلحات موضوعية: antineoplastic agent, carbonate dehydratase, enzyme inhibitor, sulfonamide, telomerase, zidovudine, animal, Bagg albino mouse, cell proliferation, chemical structure, chemistry, dose response, drug effect, drug screening, experimental neoplasm, female, human, metabolism, mouse, nude mouse, pathology, structure activity relation, synthesis, tumor cell culture, Animals, Antineoplastic Agents, Carbonic Anhydrases, Dose-Response Relationship, Drug, Drug Screening Assays

العلاقة: https://doi.org/10.1021/acs.jmedchem.1c00756Test; https://repository.rudn.ru/records/article/record/76700Test/

الإتاحة: https://doi.org/10.1021/acs.jmedchem.1c00756Test
https://repository.rudn.ru/records/article/record/76700Test/

المؤلفون: Corso, Simona, Raimondi, Alessandra, Berrino, Enrico, Tabernero Caturla, Josep, Pietrantonio, Filippo, Bellomo, Sara Erika, Manca, Paolo

المساهمون: Institut Català de la Salut, Pietrantonio F, Manca P, Raimondi A Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Bellomo SE, Corso S Department of Oncology, University of Turin, Turin, Italy. Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. Berrino E Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. Department of Medical Sciences, University of Turin, Turin, Italy. Tabernero J Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Uvic-UCC, IOB-Quiron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Estómac - Càncer - Tractament, Medicaments antineoplàstics - Ús terapèutic, Estómac - Càncer - Aspectes genètics, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Stomach Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias gástricas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada

وصف الملف: application/pdf

العلاقة: Clinical Cancer Research;29(3); https://doi.org/10.1158/1078-0432.CCR-22-2533Test; Pietrantonio F, Manca P, Bellomo SE, Corso S, Raimondi A, Berrino E, et al. HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial. Clin Cancer Res. 2023 Feb 1;29(3):571–80.; https://hdl.handle.net/11351/9411Test; 000928165300001

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-2533Test
https://hdl.handle.net/11351/9411Test

المؤلفون: Filippo Pietrantonio, Paolo Manca, Sara Erika Bellomo, Simona Corso, Alessandra Raimondi, Enrico Berrino, Federica Morano, Cristina Migliore, Monica Niger, Lorenzo Castagnoli, Serenella Maria Pupa, Caterina Marchiò, Maria Di Bartolomeo, Eleonora Restuccia, Chiara Lambertini, Josep Tabernero, Silvia Giordano

المساهمون: Institut Català de la Salut, [Pietrantonio F, Manca P, Raimondi A] Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Bellomo SE, Corso S] Department of Oncology, University of Turin, Turin, Italy. Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. [Berrino E] Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. Department of Medical Sciences, University of Turin, Turin, Italy. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Uvic-UCC, IOB-Quiron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias gástricas [ENFERMEDADES], Cancer Research, Estómac - Càncer - Tractament, Oncology, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Stomach Neoplasms [DISEASES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Estómac - Càncer - Aspectes genètics

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9373e9d52e6015dc17110ec5965cd97cTest
https://doi.org/10.1158/1078-0432.ccr-22-2533Test

المؤلفون: Enrico Berrino, Angelo Paradiso, Barbara Parodi, Vincenzo Canzonieri, Giuseppina Bonizzi, Agostino Steffan, Caterina Marchiò, Chiara Mannelli, Massimo Barberis, Pamela Arcella, Simona Di Martino, Giuseppe De Palma, Laura Annaratone, Gerardo Botti, Anna Sapino, Maria Grazia Daidone

المساهمون: Annaratone, L., De Palma, G., Bonizzi, G., Sapino, A., Botti, G., Berrino, E., Mannelli, C., Arcella, P., Di Martino, S., Steffan, A., Daidone, M. G., Canzonieri, V., Parodi, B., Paradiso, A. V., Barberis, M., Marchio, C.

المصدر: Virchows Archiv

مصطلحات موضوعية: Biobanking, 0301 basic medicine, Biomedical Research, Standardization, Process (engineering), Biospecimens, Guidelines as Topic, Accreditation, Specimen Handling, Pathology and Forensic Medicine, Tissue specimens, Biospecimen, 03 medical and health sciences, 0302 clinical medicine, Stakeholder Participation, Terminology as Topic, Biological Specimen Bank, Humans, Precision Medicine, Cell lines, Preanalytical phase, Policy Making, Molecular Biology, Biological Specimen Banks, Tissue specimen, Cell Biology, General Medicine, Medical research, Precision medicine, Biobank, 3. Good health, Review and Perspectives, 030104 developmental biology, 030220 oncology & carcinogenesis, Sustainability, Engineering ethics, Health information, Business, Cell line, Human

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e571976e0e81da7f225e64253fd763cdTest
https://doi.org/10.1007/s00428-021-03151-0Test

المؤلفون: SETTE, Miriam

المساهمون: Annunziata Berrino e Alfredo Buccaro (a cura di), Sette, Miriam

مصطلحات موضوعية: Circoli umanisti del Rinascimento, Firenze tra estetica urbana ed economia del lusso, recupero della classicità, il mito di Prometeo e di Orfeo Academies at the Renaissance time, Florence between urban aesthetics and luxury economy, recovery of the classical heritage, the myths of Prometheus and Orpheus

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/isbn/9788899930004; ispartofbook:‘Delli Aspetti de Paesi’ Vecchi e nuovi Media per l’Immagine del Paesaggio. Old and New Media for the Image of the Landscape; firstpage:1061; lastpage:1069; numberofpages:9; serie:EIKONOCITY; http://hdl.handle.net/11564/656114Test; http://www.eikonocity.it/file/07_Tomo%20I_Parte%20II_B1.pdfTest

الإتاحة: http://hdl.handle.net/11564/656114Test
http://www.eikonocity.it/file/07_Tomo%20I_Parte%20II_B1.pdfTest

المؤلفون: Claudiu T. Supuran, Anna Maria Marini, Monica Viviano, Federico Da Settimo, Sandro Cosconati, Elisabetta Barresi, Sabrina Taliani, Silvia Salerno, Sabrina Castellano, Emanuela Berrino, Emma Baglini, Rahul Ravichandran

المساهمون: Baglini, E., Ravichandran, R., Berrino, E., Salerno, S., Barresi, E., Marini, A. M., Viviano, M., Castellano, S., Da Settimo, F., Supuran, C. T., Cosconati, S., Taliani, S.

المصدر: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1874-1883 (2021)
Journal of Enzyme Inhibition and Medicinal Chemistry
article-version (VoR) Version of Record

مصطلحات موضوعية: Gene isoform, structure–activity relationship, Carbonic Anhydrase Inhibitor, carbonic anhydrases inhibitors, Proton Magnetic Resonance Spectroscopy, Drug Evaluation, Preclinical, RM1-950, tumour-related ca ix isoform, secondary sulphonamide, Structure-Activity Relationship, Carbonic anhydrase, Drug Discovery, Potency, Carbon-13 Magnetic Resonance Spectroscopy, Carbonic Anhydrase Inhibitors, Biological evaluation, Pharmacology, Sulfonamides, Bicyclic molecule, biology, tetrahydroquinazole derivative, Chemistry, Carbonic anhydrases inhibitor, Quinazoline, Computational Biology, General Medicine, Isoenzyme, Isoenzymes, Molecular Docking Simulation, secondary sulphonamides, Biochemistry, Carbonic anhydrases inhibitors, structure–activity relationships, tetrahydroquinazole derivatives, tumour-related CA IX isoform, Quinazolines, biology.protein, Therapeutics. Pharmacology, Selectivity, Research Article, Research Paper

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342dce90661ec300940c15a810da5bdeTest
https://doaj.org/article/88031813ab9443118c310ad8a0e3ccdbTest